Atlas Trials

Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805

Clinical trial NCT01424540 · COMPLETED

Trial details

NCT number
NCT01424540
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2011-09-01
Primary completion
2011-10-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.